alfapump System Commercial Implantations at University of Pennsylvania

under commercial rollout

Sequana Medical successfully completed the first commercial implantations of the alfapump System at the University of Pennsylvania, implanting two patients on the same day. The alfapump System is an active implantable medical device approved in the U.S. for treating recurrent or refractory ascites due to liver cirrhosis by automatically and continuously removing ascites fluid from the abdomen into the bladder.